您好, 歡迎來到化工儀器網(wǎng)! 登錄| 免費注冊| 產(chǎn)品展廳| 收藏商鋪|
中文摘要:
以前的研究表明神經(jīng)元引導(dǎo)分子 netrin-1 有助于減輕心肌缺血再灌注損傷。然而,組織特異性來源和受體信號轉(zhuǎn)導(dǎo)事件仍然難以捉摸。中性粒細(xì)胞是最早對缺血性損傷做出反應(yīng)的細(xì)胞之一,可能與組織損傷或救援有關(guān)。我們發(fā)現(xiàn)心肌梗死患者血液中 netrin-1 水平升高,以及暴露于心肌缺血再灌注的小鼠。在 Ntn1loxP/loxP Lyz2 Cre+ 小鼠中發(fā)現(xiàn)選擇性增加的梗死面積和肌鈣蛋白水平,但在其他組織區(qū)室中條件性 netrin-1 缺失的小鼠中沒有發(fā)現(xiàn)。使用中性粒細(xì)胞耗竭的體內(nèi)研究確定,中性粒細(xì)胞是心肌損傷期間血液 netrin-1 升高的主要來源。最后,使用重組 netrin-1 治療的藥理學(xué)研究揭示了通過髓樣腺苷 A2b 受體的嘌呤能信號事件在介導(dǎo) netrin-1 誘導(dǎo)的心臟保護(hù)中的功能作用。這些發(fā)現(xiàn)表明,中性粒細(xì)胞來源的 netrin-1 在通過髓系腺苷 A2b 信號傳導(dǎo)減輕心肌缺血再灌注損傷中具有功能作用的自分泌信號回路。
英文摘要:
Previous studies implicated the neuronal guidance molecule netrin-1 in attenuating myocardial ischemia-reperfusion injury. However, the tissue-specific sources and receptor signaling events remain elusive. Neutrophils are among the first cells responding to an ischemic insult and can be associated with tissue injury or rescue. We found netrin-1 levels were elevated in the blood of patients with myocardial infarction, as well as in mice exposed to myocardial ischemia-reperfusion. Selectively increased infarct sizes and troponin levels were found in Ntn1loxP/loxP Lyz2 Cre+ mice, but not in mice with conditional netrin-1 deletion in other tissue compartments. In vivo studies using neutrophil depletion identified neutrophils as the main source for elevated blood netrin-1 during myocardial injury. Finally, pharmacologic studies using treatment with recombinant netrin-1 revealed a functional role for purinergic signaling events through the myeloid adenosine A2b receptor in mediating netrin-1–elicited cardioprotection. These findings suggest an autocrine signaling loop with a functional role for neutrophil-derived netrin-1 in attenuating myocardial ischemia-reperfusion injury through myeloid adenosine A2b signaling.
論文信息:
論文題目: PMN-derived netrin-1 attenuates cardiac ischemia-reperfusion injury via myeloid ADORA2B signaling
期刊名稱:JEM- J Exp Med
時間期卷:J Exp Med (2021) 218 (6): e20210008.
在線時間:2021年4月23日
DOI: //doi.org/10.1084/jem.20210008
Liposoma巨噬細(xì)胞清除劑Clodronate Liposomes見刊于JEM:
Liposoma巨噬細(xì)胞清除劑Clodronate Liposomes氯膦酸二鈉脂質(zhì)體的材料和方法:
JEM期刊缺血再灌注模型外周血單核巨噬細(xì)胞清除解決方案
Mice were given 100 µl/10 g body weight i.v. clodronate liposomes (Liposoma BV) 24 h before surgery to deplete monocytes and macrophages as described before . Control mice received liposomes only at the same time points.
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業(yè)自行提供,信息內(nèi)容的真實性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),化工儀器網(wǎng)對此不承擔(dān)任何保證責(zé)任。
溫馨提示:為規(guī)避購買風(fēng)險,建議您在購買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。